ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

1.325
-0.10 (-7.02%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shield Therapeutics Plc LSE:STX London Ordinary Share GB00BYV81293 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -7.02% 1.325 1.30 1.35 1.425 1.325 1.43 2,958,047 14:52:56
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 4.47M -40.44M -0.0522 -0.25 10.24M
Shield Therapeutics Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker STX. The last closing price for Shield Therapeutics was 1.43p. Over the last year, Shield Therapeutics shares have traded in a share price range of 1.325p to 12.75p.

Shield Therapeutics currently has 775,429,360 shares in issue. The market capitalisation of Shield Therapeutics is £10.24 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -0.25.

Shield Therapeutics Share Discussion Threads

Showing 23126 to 23145 of 23150 messages
Chat Pages: 926  925  924  923  922  921  920  919  918  917  916  915  Older
DateSubjectAuthorDiscuss
24/4/2024
16:07
Re review world, conversation = "let's make a lowball offer for the rest of the shares which this weak and shareholer unfriendly mgmt will accept and who cares about the small retail shareholders.. "
cordwainer
24/4/2024
15:29
If you're the major shareholder, I wonder what conversation you're having internally
reviewwworld
24/4/2024
15:00
Well Scott I would be extremely happy to be 90% down here.Would love nothing more than to be completely wrong but this CEO has been worse than the previous which seemed impossible
best1467
24/4/2024
10:34
From day 1 I assigned zero value to Edison research. I mean, STX pay them to write it. It's like asking your best mate to write your school report. Mad that such a thing exists, sad that such a thing is permitted by the FCA.
reviewwworld
24/4/2024
00:57
re weatherman - of course, makes more sense than my mini-rant.
cordwainer
23/4/2024
19:19
Edison wrong, misled or exaggerated the research. Surly if the company starts to miss quarterly figures and you keep egging it on, you are partly to blame as investors use such research papers to get some insight into the business.
razoblade
23/4/2024
13:48
It means STX are cutting costs to the bone.
weatherman
23/4/2024
13:41
Edison announced terminating coverage along with a clutch of other small companies. Possibly because they know they were wrong.
cordwainer
22/4/2024
13:13
The reason it’s a relentless is the inside knowledge of what’s on its way .A possible default on the revenue number potentially a capital Regig which would inevitably lead to massive dilution. The only certainty is we will get the usual painful news
best1467
17/4/2024
12:59
They answer questions in these meetings, but not enough. They should show more info how to save money to get through the periods before H2 2025.
qipincha
17/4/2024
12:50
You can not ask any questions it’s staged and they pick the ones they posted themselves it’s a staged farce
best1467
17/4/2024
10:04
Very difficult to be a big player when your share price is languishing at all time lows and difficult to raise monies without more dilution.

A very promising Company years ago, management must take full responsibility for the current debacle

ny boy
16/4/2024
07:19
Results 30 April, when you can ask your Qs.
weatherman
15/4/2024
13:38
Execs and esp CEO (and maybe even NEDS) should take a pay cut they are way above average for the market cap and pocketing a significant chunk of revenue at every other shareholders expense.
cordwainer
12/4/2024
16:05
RI out of the frying pan and into the fire, white board members fail in darkest Africa, it's a pay back for colonialism!

TRP is a duffer, always looking for never ending money to finance, just confetti shares how many in issue now, must be 16 Billion + 🤡😂)0.02p should tell you everything, total nonsense.🆘⬇️ԍ18;🏻‍♀️Ԇ80;🙈

ny boy
11/4/2024
12:16
Missed a bullet now stood in front of an ak47 with TRPHa ha
bimbamboom
10/4/2024
12:33
Was it a Hardman researh report


??

riskyinvestor
10/4/2024
12:33
I was going to buy these at 8p last year because of a research report which said they are worth around 50p

I missed a bullet

Am in Tower Resources (TRP)

Where if funds allow I will be topping up every month if it stays at the 0.02p levels

riskyinvestor
09/4/2024
22:57
It was a half decent day until 4 o clock.Next update is crucial and I can't believe we can't exploit this FDA approved drug to create a profitable business and an share price many multiples of the current price.But then wtfdik.
husbod
09/4/2024
10:12
Yes, market size is tiny
qipincha
Chat Pages: 926  925  924  923  922  921  920  919  918  917  916  915  Older

Your Recent History

Delayed Upgrade Clock